Resverlogix Corp. (RVX) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.010x

Based on the latest financial reports, Resverlogix Corp. (RVX) has a cash flow conversion efficiency ratio of 0.010x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-925.52K ≈ $-669.51K USD) by net assets (CA$-94.12 Million ≈ $-68.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see RVX stock market capitalisation for the company's overall valuation and market capitalisation.

Resverlogix Corp. - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Resverlogix Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Resverlogix Corp. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Resverlogix Corp. ranked by their cash flow conversion efficiency. Explore Resverlogix Corp. (RVX) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Pantera Silver Corp
V:PNTR
-0.027x
Alpcot Holding AB Series B
ST:ALPCOT-B
-0.159x
Ulima Nitra PT
JK:UNIQ
0.040x
Nord Insuretech Group AB
ST:NORDIG
0.533x
KPX Lifescience.Co.Ltd
KQ:114450
0.095x
Panca Global Securities Tbk
JK:PEGE
-0.129x
Hamashbir 365 Holdings Ltd
TA:MSBI
0.659x
Fuji Finance Indonesia Tbk PT
JK:FUJI
0.122x

Annual Cash Flow Conversion Efficiency for Resverlogix Corp. (2001–2025)

The table below shows the annual cash flow conversion efficiency of Resverlogix Corp. from 2001 to 2025. View Resverlogix Corp. stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$-88.80 Million
≈ $-64.24 Million
CA$-3.73 Million
≈ $-2.69 Million
0.042x -11.77%
2024-12-31 CA$-81.73 Million
≈ $-59.13 Million
CA$-3.89 Million
≈ $-2.81 Million
0.048x +35.51%
2023-12-31 CA$-74.47 Million
≈ $-53.87 Million
CA$-2.61 Million
≈ $-1.89 Million
0.035x -41.26%
2022-12-31 CA$-59.28 Million
≈ $-42.88 Million
CA$-3.54 Million
≈ $-2.56 Million
0.060x -55.43%
2021-12-31 CA$-59.87 Million
≈ $-43.31 Million
CA$-8.02 Million
≈ $-5.80 Million
0.134x +121392.30%
2020-12-31 CA$-39.90 Million
≈ $-28.86 Million
CA$-4.40K
≈ $-3.18K
0.000x -99.96%
2019-12-31 CA$-64.11 Million
≈ $-46.38 Million
CA$-17.34 Million
≈ $-12.55 Million
0.271x +15.07%
2018-12-31 CA$-207.72 Million
≈ $-150.26 Million
CA$-48.83 Million
≈ $-35.33 Million
0.235x -21.73%
2017-12-31 CA$-83.68 Million
≈ $-60.53 Million
CA$-25.13 Million
≈ $-18.18 Million
0.300x +34.58%
2016-12-31 CA$-101.57 Million
≈ $-73.47 Million
CA$-22.67 Million
≈ $-16.40 Million
0.223x -41.21%
2015-12-31 CA$-56.43 Million
≈ $-40.82 Million
CA$-21.42 Million
≈ $-15.50 Million
0.380x +229.32%
2014-12-31 CA$-73.73 Million
≈ $-53.33 Million
CA$-8.50 Million
≈ $-6.15 Million
0.115x -44.80%
2013-12-31 CA$-63.22 Million
≈ $-45.73 Million
CA$-13.20 Million
≈ $-9.55 Million
0.209x -78.75%
2012-12-31 CA$-29.50 Million
≈ $-21.34 Million
CA$-29.00 Million
≈ $-20.98 Million
0.983x +111.21%
2011-12-31 CA$2.74 Million
≈ $1.98 Million
CA$-24.03 Million
≈ $-17.38 Million
-8.766x -95.92%
2010-12-31 CA$4.30 Million
≈ $3.11 Million
CA$-19.24 Million
≈ $-13.92 Million
-4.474x -8.91%
2009-12-31 CA$4.46 Million
≈ $3.23 Million
CA$-18.34 Million
≈ $-13.26 Million
-4.108x -266.55%
2008-12-31 CA$11.61 Million
≈ $8.40 Million
CA$-13.01 Million
≈ $-9.41 Million
-1.121x +68.96%
2007-12-31 CA$5.44 Million
≈ $3.94 Million
CA$-19.65 Million
≈ $-14.21 Million
-3.611x -137.13%
2006-12-31 CA$-1.02 Million
≈ $-738.42K
CA$-9.93 Million
≈ $-7.18 Million
9.724x +1749.37%
2005-12-31 CA$7.48 Million
≈ $5.41 Million
CA$-4.41 Million
≈ $-3.19 Million
-0.590x -166.26%
2004-12-31 CA$9.84 Million
≈ $7.12 Million
CA$-2.18 Million
≈ $-1.58 Million
-0.221x +35.03%
2003-12-31 CA$2.60 Million
≈ $1.88 Million
CA$-885.04K
≈ $-640.23K
-0.341x +29.20%
2002-12-31 CA$942.21K
≈ $681.58K
CA$-453.56K
≈ $-328.10K
-0.481x -1038.52%
2001-12-31 CA$259.64K
≈ $187.82K
CA$-10.98K
≈ $-7.94K
-0.042x --

About Resverlogix Corp.

TO:RVX Canada Biotechnology
Market Cap
$22.41 Million
CA$30.99 Million CAD
Market Cap Rank
#24837 Global
#957 in Canada
Share Price
CA$0.09
Change (1 day)
+0.00%
52-Week Range
CA$0.09 - CA$0.14
All Time High
CA$4.79
About

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID… Read more